Anil Motwani
Partner
Anil focuses on advising Asia-based sponsors on the formation and operation of private funds, including private equity funds, venture capital funds, real estate funds, as well as hedge funds.
Experience
Representative matters
A large Hong Kong-licensed hedge fund manager in the launch of a new, Asia-biased but market neutral hedge fund (involving consultations over, amongst other factors, the fund’s liquidity model, target concentration limits and risk/return profile).
A major non-US sovereign wealth fund in co-financing the clinical development of several potentially groundbreaking, pre-approval/market drugs/devices, including: Bempeg (a potential cure for head and neck cancer); Bardoxolone Methyl (for preventing end-stage renal disease (i.e., kidney failure)); Inclisiran (for treating heart disease using first-of-its-kind siRNA technology); and Medtronic, Inc.’s “Intrepid” transcatheter mitral valve replacement system.
The investment arm of an Asian e-commerce platform on a strategic JV investment in a German partnership designed for investment in sustainable food initiatives (e.g., alternative protein products, clean nutrition, functional food, food waste reduction).
A large Singaporean bank in the development of compliance systems and infrastructure around whether, when and how to deal with US person advisers, investors and intermediaries under covered U.S. laws and regulations.
Pro bono
Partnering with Lawyers Without Borders to prepare research material aimed at combatting the ivory trade in Tanzania, including meetings and trainings with key stakeholders in Dar es Salaam
Co-authoring a research paper with International Rivers to seek protected status for a river in Myanmar which had been dammed upstream
Published Work
- Chen, L. X., Motwani A., Zhang J., Gao N., (2024), “Chambers Global Practice Guide: Investment Funds: Hong Kong Law and Practice Chapter”, London: Chambers and Partners
- Chen, L. X., Motwani A., Fu F., Lin E., (2024), “ESG Regulatory Trend: Visions of A Unitary Regime”, Hong Kong Venture Capital and Private Equity Association Journal
- Chen, L. X., Motwani A., Zhang J., Gao N., (2023), “The Private Equity Review: Hong Kong Fundraising Chapter”, London: Law Business Research Ltd
- Chen, L. X., Motwani A., Zhang J., Gao N., (2023), “Chambers Global Practice Guide: Investment Funds: Hong Kong Law and Practice Chapter”, London: Chambers and Partners
Speaking Engagements
- Presenter, Regulatory Update in Hong Kong and the United States, Shearman & Sterling and the Hong Kong Venture Capital and Private Equity Association, September 2023
- Presenter, Understanding Financial Statements for In-House Lawyers, ACC, August 2023
- Presenter, Measures by Licensed Corporations to Deal with Stress Events, Shearman & Sterling and the Hong Kong Venture Capital and Private Equity Association, December 2022
- Speaker, Legal Aspects of ESG Investment, Shearman & Sterling and Association of Corporate Counsel Hong Kong, August 2022
Awards
- Recommended Lawyer for Investment Funds in China, The Legal 500 Asia Pacific, 2024
- Recommended Lawyer for Investment Funds in Hong Kong, The Legal 500 Asia Pacific, 2024
- Leading Lawyer - Rising Star in Hong Kong Investment Funds, IFLR1000, 2023-2024
Qualifications
Admissions
Hong Kong, 2020
Academic
J.D., Columbia Law School, 2013